Alpha Cognition Inc. Secures $4.545M in Bridge Financing
Company Announcements

Alpha Cognition Inc. Secures $4.545M in Bridge Financing

Story Highlights

Alpha Cognition Inc (TSE:ACOG) has released an update.

Alpha Cognition Inc., a biopharmaceutical company, has successfully completed a bridge financing round, raising $4.545 million through convertible notes and warrants. The funding attracted both existing and new investors, with the notes set to mature in 2026 and bearing a 10% annual interest, payable in common shares. This strategic financial move is aimed at bolstering the company’s development of therapies for neurodegenerative disorders.

For further insights into TSE:ACOG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskAlpha Cognition Plans Nasdaq Listing and $25M Offering
TipRanks Canadian Auto-Generated NewsdeskAlpha Cognition Inc. Appoints New Finance VP
TipRanks Canadian Auto-Generated NewsdeskAlpha Cognition Secures U.S. Patent for Alzheimer’s Drug
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App